Клинические примеры трансплантации тканеинженерной конструкции для восполнения дефицита костной ткани в области дна верхнечелюстной пазухи

Представлены клинические примеры лечения пациентов с вторичной адентией и выраженным дефицитом костной ткани в области верхней челюсти с помощью тканеинженерной конструкции. В качестве источника мультипатентных стромальных клеток использовалась жировая ткань.

Clinical examples of treatment of patients with secondary absence of teeth and the expressed deficiency of a bone fabric in the field of the top jaw with the help tissue engineering of bone. As a source multipatent stem cells cages the fatty fabric was used.

тканевая инженерия, мультипатентные стромальные клетки, синус-лифтинг, костная ткань.

tissue engineering, multipatent stem cells, sinus lift, bone tissue.

1. Del Fabbro M, Testori T, Francetti L, Weinstein R. Systematic review of survival rates for implants placed in the grafted maxillary sinus. Int J Periodontics Restorative Dent. 2004 Dec; 24 (6): 565-77.
2. Gapski R, Misch C, Stapleton D, Mullins S, Cobb C, Vansanthan A, Reissner M., Histological, histomorphometric, and radiographic evaluation of a sinus augmentation with a new bone allograft: a clinical case report. Clin Oral Implants Res. 2009 Feb; 20(2):175-82.
3. Ito K, Yamada Y, Nagasaka T, Baba S, Ueda M. Osteogenic potential of injectable tissue-engineered bone: a comparison among autogenous bone, bone substitute (Bio-oss), plateletrich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mater Res A. 2005 Apr 1;73(1):63-72.
4. Mangano C, Piattelli A, Mangano F, Borges F, Iezzi G, Mangano A, d’Avila S, Tettamanti LT, Shibli J. Engineered bone by autologous osteoblasts on polimeric scaffolds in maxillary sinus augmentation: histological report (странный шрифт). J Oral Implantol. 2010 Jun 14.
5. Mangano C, Piattelli A, Mangano A, Mangano F, Mangano A, Iezzi G, Borges FL, d’Avila S, Shibli JA., Combining scaffolds and osteogenic cells in regenerative bone surgery: a preliminary histological report in human maxillary sinus augmentation.Br J Oral Maxillofac Surg. 2010 Jun; 48(4): 285-90.
6. Mangano C, Piattelli A, Tettamanti L, Mangano F, Mangano A, Borges F, Iezzi G, d’Avila S, Shibli JA. Engineered bone by autologous osteoblasts on polymeric scaffolds in maxillary sinus augmentation: histologic report. J Oral Implantol. 2010; 36 (6): 491-6.
7. Pettinicchio M, Traini T, Murmura G, Caputi S, Degidi M, Mangano C, Piattelli A. Histologic and histomorphometric results of three bone graft substitutes after sinus augmentation in humans. Clin Oral Investig. 2010 Nov 3.
8. Schmelzeisen R, Gutwald R, Oshima T, Nagursky H, Vogeler M, Sauerbier S. Making bone II: maxillary sinus augmentation with mononuclear cells-case report with a new clinical method. Br J Oral Maxillofac Surg. 2010 Jul 31.
9. Tarnow DP, Wallace SS, Testori T, Froum SJ, Motroni A, Prasad HS. Maxillary sinus augmentation using recombinant bone morphogenetic protein-2/acellular collagen sponge in combination with a mineralized bone replacement graft: a report of three cases. Int J Periodontics Restorative Dent. 2010 Apr;30(2):139-49.
10. Yamada Y, Nakamura S, Ito K, Kohgo T, Hibi H, Nagasaka T, Ueda M. Injectable tissue-engineered bone using autogenous bone marrow-derived stromal cells for maxillary sinus augmentation: clinical application report from a 2-6-year follow-up. Tissue Eng Part A. 2008 Oct;14(10):1699-707.